Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity.
Elife
; 72018 07 25.
Article
in En
| MEDLINE
| ID: mdl-30039798
ABSTRACT
The early-life intestinal microbiota plays a key role in shaping host immune system development. We found that a single early-life antibiotic course (1PAT) accelerated type 1 diabetes (T1D) development in male NOD mice. The single course had deep and persistent effects on the intestinal microbiome, leading to altered cecal, hepatic, and serum metabolites. The exposure elicited sex-specific effects on chromatin states in the ileum and liver and perturbed ileal gene expression, altering normal maturational patterns. The global signature changes included specific genes controlling both innate and adaptive immunity. Microbiome analysis revealed four taxa each that potentially protect against or accelerate T1D onset, that were linked in a network model to specific differences in ileal gene expression. This simplified animal model reveals multiple potential pathways to understand pathogenesis by which early-life gut microbiome perturbations alter a global suite of intestinal responses, contributing to the accelerated and enhanced T1D development.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 1
/
Gastrointestinal Microbiome
/
Immunity, Innate
/
Anti-Bacterial Agents
Limits:
Animals
Language:
En
Journal:
Elife
Year:
2018
Document type:
Article
Affiliation country: